HEALTH.2013.2.4.2-1
HEALTH.2013.2.4.2-1
9 projects · €52,873,536 total EU contribution (project-level) · 90 participating organizations · 19 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€52,873,536
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (16)
- Netherlands (10)
- UK (10)
- France (8)
- Italy (8)
- CH (7)
- Spain (6)
- SE (6)
- AT (4)
- DK (4)
- FI (2)
- AU (1)
- BE (1)
- CA (1)
- EL (1)
- IE (1)
- IL (1)
- IS (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- KI4 projects · SE
- UOXF3 projects · UK
- ALTA SRLU2 projects · IT
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 projects · DE
- HMGU2 projects · DE
- BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS2 projects · EL
- INSERM2 projects · FR
- Santaris2 projects · DK
- UMC UTRECHT2 projects · NL
- UNIGE2 projects · CH
- NUID UCD2 projects · IE
- 4SC DISCOVERY1 projects · DE
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Identification and validation of novel pharmaceutical drug targets for cardiovascular disease CARTARDIS · 602936 | FP7 | €5,973,521 | €7,980,425 | Details |
Targeting novel lipid pathways for treatment of cardiovascular disease Athero-Flux · 602222 | FP7 | €5,987,700 | €7,860,933 | Details |
Systems Biology to Identify Molecular Targets for Vascular Disease Treatment SYSVASC · 603288 | FP7 | €5,976,413 | €8,350,348 | Details |
MULTISCALE APPROACH TO THE IDENTIFICATION OF MOLECULAR BIOMARKERS IN ACUTE HEART FAILURE INDUCED BY SHOCK SHOCKOMICS · 602706 | FP7 | €5,174,001 | €6,703,317 | Details |
Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention CVGENES-AT-TARGET · 601456 | FP7 | €5,995,449 | €7,876,515 | Details |
Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETS · 602904 | FP7 | €6,000,000 | €8,178,399 | Details |
Targeting and exploiting B cell functions for treatment in cardiovascular disease Athero-B-Cell · 602114 | FP7 | €5,892,178 | €7,739,594 | Details |
Treating stroke with Affibody molecules targeting the inflammatory mediator HMGB1 COUNTERSTROKE · 602354 | FP7 | €5,989,631 | €7,843,759 | Details |
Translating disease to cardiovascular health TransCard · 603091 | FP7 | €5,884,643 | €7,627,897 | Details |